What is the difference between Cervarix and Gardasil?

There are two vaccines that protect against those dangerous HPV strains: Cervarix, used in the UK, blocks HPV 16 and 18; whereas Gardasil protects against strains 6, 11, 16 and 18. So the main difference between both vaccines is that Gardasil also protects against HPV 6 and 11, which cause most cases of genital warts.

Why was Cervarix taken off the market?

“GSK recently made the decision to stop supplying Cervarix in the U.S. due to very low market demand,” the spokesperson said. “With another HPV vaccine available in the U.S., patients will continue to have an option to help prevent HPV infection.

What was the HPV vaccine 2010?

In 2010, Gardasil was approved by the FDA for prevention of anal cancer and associated precancerous lesions due to HPV types 6, 11, 16, and 18 in people aged 9 through 26 years.

Did Gardasil 9 replace Gardasil?

Gardasil, a vaccine approved by the FDA in 2006 to prevent certain cancers and diseases caused by four HPV types, is no longer distributed in the U.S. In 2014, the FDA approved Gardasil 9, which covers the same four HPV types as Gardasil, as well as an additional five HPV types.

Can I get Gardasil 9 after Cervarix?

Answer: Clinical studies have assured both efficacy and safety of the 9-valent HPV vaccine after receiving GARDASIL® or CERVARIX® longer than a year.

Can Gardasil and Cervarix be used interchangeably?

With the licensure of GlaxoSmithKline’s human papillomavirus vaccine Cervarix in October, we will soon have two vaccines that prevent cervical cancer in women. But they’re not interchangeable, and this could lead to problems.

Is Cervarix still on the market?

GlaxoSmithKline (GSK) will no longer market its human papillomavirus (HPV) bivalent vaccine, Cervarix, in the United States, according to an industry newsletter report last week. Cervarix protects against infection from HPV types 16 and 18.

What HPV vaccine was used in 2009?

On October 16, 2009, the Food and Drug Administration (FDA) licensed bivalent human papillomavirus vaccine (HPV2; Cervarix, GlaxoSmithKline) for use in females aged 10 through 25 years. Cervarix is the second human papillomavirus (HPV) vaccine licensed for use in females in the United States.

Are Cervarix and Gardasil interchangeable?

Which HPV vaccine is the best?

Gardasil 9 Cervarix provides protection against HPV types 16 and 18, which account for 70% of all cervical cancers, and have been shown to be both clinically- and cost-effective in the local setting for females. Gardasil 9 provides protection against an additional 20% of cancer-causing HPV types.

Why is Cervarix not available in the US?

“GSK recently made the decision to stop supplying Cervarix in the US due to very low market demand,” a company spokesperson told the newsletter Fierce Pharma. GSK’s vaccine sales in the United States last year accounted for only £3 million of the £88 million ($107 million) worldwide sales total.

When did the FDA approve Cervarix?

On October 16, 2009, the Food and Drug Administration (FDA) licensed bivalent human papillomavirus vaccine (HPV2; Cervarix, GlaxoSmithKline) for use in females aged 10 through 25 years.

Why did they discontinue Gardasil?

They cited a lack of adequate long-term testing of the vaccine, unproven efficacy and disturbing news of adverse side effects such as neurological disorders.